Lucas Zier, MD
Interventional Cardiology · San Francisco, CANPI 1952636540
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,483 of the $5,113 with a category attached, or 68.1%. 13 manufacturers reported payments, led by Procyrion, Inc. at 42.2% of the total. That places this record below the midpoint for interventional cardiology clinicians in CA, where the typical reported total is $8,581.
Across 60 payments — averaging $85.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procyrion, Inc.$2K
- Boston Scientific$979
- Cardiovascular Systems Inc.$725
- Medtronic$335
- Abiomed$275
- Abbott$182
- plus $462 from 7 others
Across 1 payment — averaging $89,687 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Procyrion, Inc.$90K
What the payments were for
- Consulting fees$1,60031%
- Food & beverage$3,48368%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procyrion, Inc. | 5 | $2,155 |
| Boston Scientific | 24 | $979 |
| Cardiovascular Systems Inc. | 9 | $725 |
| Medtronic(2 entities) | 6 | $335 |
| Abiomed | 6 | $275 |
| Abbott | 2 | $182 |
| Edwards Lifesciences | 1 | $173 |
| Asahi Intecc USA, Inc. | 2 | $156 |
| Teleflex LLC | 1 | $37 |
| Shockwave Medical, Inc | 1 | $30 |
| Boehringer Ingelheim | 1 | $30 |
| Philips North America LLC | 1 | $25 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,113 in reported general payments places this provider in the 35th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpsumitMacitentan | 20 | $238,034 |
| EliquisApixaban | 13 | $8,453 |
| ClopidogrelClopidogrel Bisulfate | 17 | $60 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in San Francisco
- Yousif AhmadSan Francisco$205K
- Bao TranSan Francisco$130K
- Sammy ElmariahSan Francisco$126K
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Rahul SharmaStanford$1M
- Puneet KhannaRancho Mirage$1M
- Dennis SheehanRedwood City$900K
- Suhail DohadBeverly Hills$802K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.